Vice President and Enterprise Head of Cell and Gene Therapy at Labcorp Drug Development
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Indianapolis Site Head, VP | Precision Medicine, Testing Enablement & Expanded Lab Mgmt. Solutions
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
🌟 Talent Acquisition Manager at Labcorp | Passionate about Connecting Talent with Opportunity and Leading the Future Recruiters| Champion for Military, Military Spouses, and Veterans 🌟
Companion diagnostics (CDx) can improve clinical outcomes and reduce costs associated with clinical trial research and development. Learn about important CDx considerations and how Labcorp can help advance your global CDx program: #CDx #CompanionDiagnostics #PrecisionMedicine
Our partnership with Indica Labs and collaboration on the HALO AP digital pathology platform will enhance our cutting-edge pathology services for our clients and clinicians.
We are pleased to announce that Molecular Pathology Laboratory Network, Inc. (MPLN) has selected HALO AP to deliver digital pathology services to both clinical reference labs and biopharma clients. As MPLN’s Dr. Ravyn Duncan, Vice President, Scientific Operations and Research, stated, “our goal with digital pathology is to improve diagnostic efficiency while maintaining regulatory compliance and providing the highest standard of patient care.” We’re excited to work with MPLN on implementing digital pathology workflows to meet this goal, and encourage you to read our press release to learn more about the deployment and HALO AP: https://lnkd.in/gyrT6jQm #DigitalPathology #TissueAnalysis #PathologyLabs #ClinicalTrials #HALOap #IndicaLabs
Indica Labs announced today that Molecular Pathology Laboratory Network, Inc. (MPLN) has selected HALO AP to deliver digital pathology services to both clinical reference labs and biopharma clients. Check out Indica's press release to learn more about the deployment and HALO AP: #DigitalPathology #TissueAnalysis #PathologyLabs #ClinicalTrials #HALOap #InidcaLabs
We are pleased to announce that Molecular Pathology Laboratory Network, Inc. (MPLN) has selected HALO AP to deliver digital pathology services to both clinical reference labs and biopharma clients. As MPLN’s Dr. Ravyn Duncan, Vice President, Scientific Operations and Research, stated, “our goal with digital pathology is to improve diagnostic efficiency while maintaining regulatory compliance and providing the highest standard of patient care.” We’re excited to work with MPLN on implementing digital pathology workflows to meet this goal, and encourage you to read our press release to learn more about the deployment and HALO AP: https://lnkd.in/gyrT6jQm #DigitalPathology #TissueAnalysis #PathologyLabs #ClinicalTrials #HALOap #IndicaLabs
We are pleased to announce that Molecular Pathology Laboratory Network, Inc. (MPLN) has selected HALO AP to deliver digital pathology services to both clinical reference labs and biopharma clients. As MPLN’s Dr. Ravyn Duncan, Vice President, Scientific Operations and Research, stated, “our goal with digital pathology is to improve diagnostic efficiency while maintaining regulatory compliance and providing the highest standard of patient care.” We’re excited to work with MPLN on implementing digital pathology workflows to meet this goal, and encourage you to read our press release to learn more about the deployment and HALO AP: https://lnkd.in/gyrT6jQm #DigitalPathology #TissueAnalysis #PathologyLabs #ClinicalTrials #HALOap #IndicaLabs
